Skip to content
Catalyst
Search

Papers/PMID:32050924

Serum magnesium, mortality and disease progression in chronic kidney disease.

BMC nephrology2020The record

1 finding · 1 compound · 1 endpoint

What it reported

How to read these marks

What moved

1 finding

  • magnesium(2+) — increases all-cause mortality

    Evidence strength: very limited.Findingreplicated ×1
    “Magnesium level > 2.6 mg/dl 1 (vs. 1.7–2.6 mg/dl) was associated with a higher risk of all-cause death only (HR = 1.23, 95% CI: 1.03, 1.48).”
    Quoted verbatim from Serum magnesium, mortality and disease progression in chronic kidney disease..
    Study
    cohort
    Population
    Patients with CKD stage 3 or 4 in the Cleveland Clinic registry whose baseline serum magnesium was above 2.6 mg/dl, compared with 1.7-2.6 mg/dl; median follow-up 3.7 years

    Effect 1.23 hazard ratio, 95% CI 1.03 to 1.48

    Serum magnesium, mortality and disease progression in chronic kidney disease.2020PMID:3205092410.1186/s12882-020-1713-3Industry fundedPermalink